Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company pioneering […]
NHS Set to Eliminate Hepatitis C Ahead of Rest of the World
The NHS is on track to eliminate Hepatitis C by 2025 thanks to a pioneering […]
Colleen Flesher Appointed Co-CEO for Movora
Colleen Flesher, currently COO Movora, has been appointed new Co-CEO of veterinary MedTech leader Movora, […]
Oscar Health Announces Expansion with Vanderbilt University Medical Center To Provide In-Network Health Coverage for Residents Across the Nashville Region
Oscar Health, the first health insurance company built on a full stack technology platform, has […]
Liminatus Pharma and Iris Acquisition Corp to Combine to Incorporate and Accelerate Much-needed Cancer Treatments
Liminatus Pharma LLC, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition […]
SpectrumX’s Hand Sanitiser Approved for NHS Supply Chain’s NHS Supplier List
SpectrumX, a UK-based healthcare and pharmaceutical company, has announced that it has officially been informed, […]
Sonrava Health Enters Strategic Alliance with FCL Dental, Owner of One of the Nation’s Largest Independent Dental Benefits Companies
Sonrava Health has announced that it has entered into a strategic alliance with FCL Dental, […]
COVID-19 Patients Show Liver Injury Months After Infection
COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, […]
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
Johnson & Johnson has announced that its Board of Directors has elected CEO, Mr. Joaquin […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more